
Hepatologist

No OPD information available
Cirrhosis
Non-Alcoholic Fatty Liver Disease
Hepatitis
Hepatitis C
Nonalcoholic Steatohepatitis (NASH)
Alexander D. Hodge is a male healthcare provider who helps people with liver problems like cirrhosis, fatty liver disease, hepatitis, and more. He uses his special skills and treatments to care for patients and make them feel better.
When Alexander D. Hodge talks to patients, he listens carefully and explains things in a way that is easy to understand. Patients trust him because he is kind, knowledgeable, and always there to help.
To stay updated with the latest medical knowledge, Alexander D. Hodge reads research papers, attends conferences, and learns from other experts in the field. This helps him provide the best care possible to his patients.
Alexander D. Hodge works well with other medical professionals, collaborating and sharing ideas to improve patient outcomes. His relationships with colleagues are strong, and together they strive to provide top-notch care to those in need.
Thanks to Alexander D. Hodge's work, many patients have seen positive changes in their health and lives. His dedication and expertise have made a real difference in the well-being of those he treats.
In one of his notable publications, Alexander D. Hodge discussed the connections between liver disease, heart problems, and aspirin use in older adults. This research helps improve our understanding of these conditions and how to manage them better.
Additionally, Alexander D. Hodge is involved in a clinical trial to study a new treatment for preventing complications in patients with liver disease. This trial shows his commitment to finding innovative solutions to help his patients.
Overall, Alexander D. Hodge is a caring and skilled healthcare provider who works tirelessly to improve the lives of those with liver conditions. His dedication to learning, collaboration with colleagues, and positive impact on patients make him a valued member of the medical community.
Enrollment Status: Active not recruiting
Published: April 11, 2025
Intervention Type: Drug
Study Drug: Belapectin
Study Phase: Phase 2/Phase 3
